iBio Stock Forecast for 2023 - 2025 - 2030
Updated on 05/02/2024
iBio Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, iBio's Price has grown by 100.00%, rising from $0.00 to $0.00. For next year, analysts predict Fair Value of $0.00, which would mean an increase of 100.00%. Over the next six years, experts predict that iBio's Fair Value will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ABBV Stock Forecast | AbbVie | Outperform |
9
|
$161.72 | Buy/Sell | $178.42 | 15.01% |
| AMGN Stock Forecast | Amgen | Outperform |
4
|
$277.37 | Buy/Sell | $303.65 | 15.19% |
| GILD Stock Forecast | Gilead Sciences Inc | Outperform |
11
|
$65.51 | Buy/Sell | $87.82 | 22.12% |
| ALXN Stock Forecast | Alexion Pharmaceuticals | - |
0
|
$182.50 | Buy/Sell | $177.38 | -100.00% |
| BIIB Stock Forecast | Biogen | Outperform |
10
|
$216.13 | Buy/Sell | $299.62 | 33.48% |
iBio Revenue Forecast for 2023 - 2025 - 2030
In the last two years, iBio's Revenue has grown by 14.63%, rising from $1.64M to $1.88M. For next year, analysts predict Revenue of $2.01M, which would mean an increase of 7.11%. Over the next eight years, experts predict that iBio's Revenue will grow at a rate of 7.62%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BMRN Stock Forecast | BioMarin Pharmaceutical | Outperform |
10
|
$83.33 | Buy/Sell | $111.56 | 32.01% |
| INCY Stock Forecast | Incyte | Outperform |
9
|
$52.94 | Buy/Sell | $77.05 | 45.83% |
| VKTX Stock Forecast | Viking Therapeutics | Buy |
5
|
$76.43 | Buy/Sell | $34.00 | 50.46% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ARNA Stock Forecast | Arena Pharmaceuticals | - |
6
|
$99.99 | Buy/Sell | $100.00 | -100.00% |
| BPMC Stock Forecast | Blueprint Medicines | Outperform |
6
|
$94.86 | Buy/Sell | $85.71 | 5.42% |
| CCXI Stock Forecast | ChemoCentryx | - |
8
|
$51.99 | Buy/Sell | $52.00 | -100.00% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CBAY Stock Forecast | CymaBay Therapeutics | - |
8
|
$32.44 | Buy/Sell | $27.73 | -100.00% |
| IOVA Stock Forecast | Iovance Biotherapeutics | Buy |
4
|
$12.50 | Buy/Sell | $20.42 | 104.00% |
| DRNA Stock Forecast | Dicerna Pharmaceuticals | - |
7
|
$38.01 | Buy/Sell | $35.06 | -100.00% |
iBio EBITDA Forecast for 2023 - 2025 - 2030
iBio's EBITDA has grown In the last three years, rising from $-11.76M to $-28.05M – a growth of 138.52%. According to 0 major analysts, iBio's EBITDA will fall by 18.97% in the next year, reaching $-22.73M. Professionals believe that By 2030, iBio's EBITDA will fall to $-25.64M– a 8.58% decrease from its current value.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| FOLD Stock Forecast | Amicus Therapeutics | Outperform |
7
|
$10.43 | Buy/Sell | $17.90 | 91.75% |
| ARWR Stock Forecast | Arrowhead Pharmaceuticals | Outperform |
7
|
$23.17 | Buy/Sell | $52.00 | 128.74% |
| ACAD Stock Forecast | ACADIA Pharmaceuticals | Outperform |
6
|
$17.05 | Buy/Sell | $33.78 | 75.07% |
iBio EBIT Forecast for 2023 - 2025 - 2030
iBio's EBIT has seen impressive growth In the last three years, rising from $-14.00M to $-28.78M – a growth of 105.57%. In the next year, 0 analysts estimate that iBio's EBIT will decrease by 15.77%, reaching $-24.24M. According to professional forecasts, in 2030, iBio's EBIT will decrease by 6.25%, reaching $-26.98M.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CLDX Stock Forecast | Celldex Therapeutics | Buy |
11
|
$39.35 | Buy/Sell | $63.29 | 95.68% |
| VCEL Stock Forecast | Vericel | Buy |
8
|
$47.08 | Buy/Sell | $42.58 | 16.82% |
| AGIO Stock Forecast | Agios Pharmaceuticals | Outperform |
9
|
$33.66 | Buy/Sell | $40.00 | 29.23% |
iBio EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, iBio's EPS has grown by 100.00%, rising from $-305.00 to $0.00. For next year, analysts predict EPS of $0.00, which would mean an increase of 100.00%. Over the next six years, experts predict that iBio's EPS will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ADMA Stock Forecast | ADMA Biologics | Buy |
9
|
$6.67 | Buy/Sell | $6.00 | 19.94% |
| ARDX Stock Forecast | Ardelyx | Buy |
11
|
$6.61 | Buy/Sell | $9.94 | 104.24% |
| DVAX Stock Forecast | Dynavax Technologies | Outperform |
11
|
$11.68 | Buy/Sell | $25.00 | 109.76% |
.jpg)